Mainstream

Zevra Therapeutics GAAP EPS of -$0.06 beats by $0.13, revenue of $20.4M beats by $3.44M

Zevra Therapeutics GAAP EPS of -$0.06 beats by $0.13, revenue of $20.4M beats by $3.44M

Post ContentzvraRead More

You might also be interested in reading DeepSeek hints that China has mastered the art of ‘kaizen’ — the west should be worried.

May 14, 2025
In Mainstream